<?xml version="1.0" encoding="UTF-8"?>
<p>Following what has been done for other chronic or acute viral infections,
 <xref rid="psp412510-bib-0011" ref-type="ref">
  <sup>11</sup>
 </xref>, 
 <xref rid="psp412510-bib-0012" ref-type="ref">
  <sup>12</sup>
 </xref>, 
 <xref rid="psp412510-bib-0013" ref-type="ref">
  <sup>13</sup>
 </xref> we here show how the techniques of mathematical modeling have been instrumental to better understand the immune‚Äêpathogenesis of Ebola virus disease (EVD) and to optimize the use of favipiravir. In addition, we discuss the implications of this work for other emerging viruses.
</p>
